When did KINNATE BIOPHARMA INC (KNTE) report earnings last quarter?
KINNATE BIOPHARMA INC (KNTE) last reported earnings on 3/28/2024.
KINNATE BIOPHARMA INC (KNTE) Earnings History & Surprises
NASDAQ:KNTE • US49705R1059
Current stock price
2.65 USD
-0.01 (-0.38%)
At close:
2.65 USD
0 (0%)
After Hours:
KNTE Earnings overview
Past quarterly earnings results for KINNATE BIOPHARMA INC (KNTE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 9, 2024
- Period
- Q1 / 2024
- EPS Estimate
- -$0.37
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Mar 28, 2024
- Period
- Q4 / 2023
- EPS Reported
- -$0.36
- EPS Surprise
- 16.96%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2023 | -0.36 | -0.43 | 16.96% | 50.00% | - | - | ||
| Q3 2023 | -0.65 | -0.69 | 5.59% | 7.14% | - | - | ||
| Q2 2023 | -0.68 | -0.77 | 11.11% | -9.68% | - | - | ||
| Q1 2023 | -0.73 | -0.74 | 1.96% | -19.67% | - | - | ||
| Q4 2022 | -0.72 | -0.73 | 1.37% | -20.00% | - | - | ||
| Q3 2022 | -0.70 | -0.62 | -12.97% | -22.81% | - | - | ||
| Q2 2022 | -0.62 | -0.65 | 4.84% | -26.53% | - | - | ||
| Q1 2022 | -0.61 | -0.62 | 1.50% | -52.50% | - | - | ||
| Q4 2021 | -0.60 | -0.60 | -0.19% | -87.50% | - | - | ||
| Q3 2021 | -0.57 | -0.55 | -3.49% | -43.29% | - | - | ||
| Q2 2021 | -0.49 | -0.44 | -11.72% | - | - | - | ||
| Q1 2021 | -0.40 | -0.37 | -8.18% | - | - | - | ||
| Q4 2020 | -0.32 | -0.38 | 15.78% | - | - | - | ||
| Q3 2020 | -0.40 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
8.90%
Max EPS beat (4)
16.96%
Min EPS beat (4)
1.96%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, KNTE has consistently beaten EPS estimates in all releases
In the last 4 quarters, KNTE has beaten the EPS estimates by 8.9% on average.
Related analysis
KINNATE BIOPHARMA INC / KNTE Earnings FAQ
Did KNTE stock beat earnings estimates in the most recent quarter?
KINNATE BIOPHARMA INC (KNTE) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does KNTE stock beat earnings estimates?
In the last 4 quarters, KINNATE BIOPHARMA INC (KNTE) has beaten EPS estimates in 4 out of 4 releases.